Delivery Order SPE2DB22D2206-SPE2DB25FJV33
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,898.52 to AmerisourceBergen Drug Corp for IBSRELA 50 MG tablets (60-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle...
- This is a $13,791.57 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S medication. The contract has an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a $4,865.97 delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 4, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this...
- The Defense Logistics Agency awarded a $10,409.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's...
- This is a $6,272.42 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,971.92 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger relationship...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication IBSRELA 50 MG TABLET. The contract has a firm fixed price of $2,395.04 and a period of performance through April 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This is a $19,116.90 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, with a period of performance through June 11, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $72,986.26 firm fixed-price contract is for the delivery of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has a completion date of June 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.01 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...